Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.

Erskine D, Taylor JP, Thomas A, Collerton D, McKeith I, Khundakar A, Attems J, Morris C.

Neurosci Bull. 2019 Feb 6. doi: 10.1007/s12264-019-00341-4. [Epub ahead of print] No abstract available.

PMID:
30729454
2.

A comparison of visual hallucinations across disorders.

Dudley R, Aynsworth C, Mosimann U, Taylor JP, Smailes D, Collerton D, McCarthy-Jones S, Urwyler P.

Psychiatry Res. 2018 Dec 8;272:86-92. doi: 10.1016/j.psychres.2018.12.052. [Epub ahead of print]

PMID:
30579187
3.

The utility and application of electrophysiological methods in the study of visual hallucinations.

daSilva Morgan K, Elder GJ, Ffytche DH, Collerton D, Taylor JP.

Clin Neurophysiol. 2018 Nov;129(11):2361-2371. doi: 10.1016/j.clinph.2018.08.019. Epub 2018 Sep 6. Review.

PMID:
30253375
4.

Prevalence and characteristics of multi-modal hallucinations in people with psychosis who experience visual hallucinations.

Dudley R, Aynsworth C, Cheetham R, McCarthy-Jones S, Collerton D.

Psychiatry Res. 2018 Nov;269:25-30. doi: 10.1016/j.psychres.2018.08.032. Epub 2018 Aug 13.

PMID:
30145297
5.

Reduced occipital GABA in Parkinson disease with visual hallucinations.

Firbank MJ, Parikh J, Murphy N, Killen A, Allan CL, Collerton D, Blamire AM, Taylor JP.

Neurology. 2018 Aug 14;91(7):e675-e685. doi: 10.1212/WNL.0000000000006007. Epub 2018 Jul 18.

6.

Coping with Cognitive Impairment in People with Parkinson's Disease and Their Carers: A Qualitative Study.

Lawson RA, Collerton D, Taylor JP, Burn DJ, Brittain KR.

Parkinsons Dis. 2018 Apr 8;2018:1362053. doi: 10.1155/2018/1362053. eCollection 2018.

7.

The Structure and Measurement of Unusual Sensory Experiences in Different Modalities: The Multi-Modality Unusual Sensory Experiences Questionnaire (MUSEQ).

Mitchell CAA, Maybery MT, Russell-Smith SN, Collerton D, Gignac GE, Waters F.

Front Psychol. 2017 Aug 11;8:1363. doi: 10.3389/fpsyg.2017.01363. eCollection 2017.

8.

Measures of visual hallucinations: Review and recommendations.

Aynsworth C, Collerton D, Dudley R.

Clin Psychol Rev. 2017 Nov;57:164-182. doi: 10.1016/j.cpr.2017.05.001. Epub 2017 May 11. Review.

PMID:
28844297
9.

Reality monitoring performance and the role of visual imagery in visual hallucinations.

Aynsworth C, Nemat N, Collerton D, Smailes D, Dudley R.

Behav Res Ther. 2017 Oct;97:115-122. doi: 10.1016/j.brat.2017.07.012. Epub 2017 Jul 20.

PMID:
28755572
10.

Compensatory shifts in visual perception are associated with hallucinations in Lewy body disorders.

Bowman AR, Bruce V, Colbourn CJ, Collerton D.

Cogn Res Princ Implic. 2017;2(1):26. doi: 10.1186/s41235-017-0063-6. Epub 2017 May 24.

11.

Cognitive impairment in Parkinson's disease: impact on quality of life of carers.

Lawson RA, Yarnall AJ, Johnston F, Duncan GW, Khoo TK, Collerton D, Taylor JP, Burn DJ; ICICLE-PD study group.

Int J Geriatr Psychiatry. 2017 Dec;32(12):1362-1370. doi: 10.1002/gps.4623. Epub 2016 Dec 7.

12.

What Is the Link Between Hallucinations, Dreams, and Hypnagogic-Hypnopompic Experiences?

Waters F, Blom JD, Dang-Vu TT, Cheyne AJ, Alderson-Day B, Woodruff P, Collerton D.

Schizophr Bull. 2016 Sep;42(5):1098-109. doi: 10.1093/schbul/sbw076. Epub 2016 Jun 29. Review.

13.

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention.

Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH, Barker RA, Collerton D, Taylor JP, Burn DJ; ICICLE-PD study group.

Parkinsonism Relat Disord. 2016 Jun;27:47-53. doi: 10.1016/j.parkreldis.2016.04.009. Epub 2016 Apr 11.

14.

Visual Hallucinations in Eye Disease and Lewy Body Disease.

Urwyler P, Nef T, Müri R, Archibald N, Makin SM, Collerton D, Taylor JP, Burn D, McKeith I, Mosimann UP.

Am J Geriatr Psychiatry. 2016 May;24(5):350-8. doi: 10.1016/j.jagp.2015.10.007. Epub 2015 Oct 21.

PMID:
26796926
15.

Visual Hallucinations in Older People: Appraisals but not Content or Phenomenology Influence Distress.

Lai S, Bruce V, Collerton D.

Behav Cogn Psychother. 2016 Nov;44(6):705-710. Epub 2015 Nov 4.

PMID:
26530689
16.

Visual Priming and Visual Hallucinations in Parkinson's Disease. Evidence for Normal Top-Down Processes.

Straughan S, Collerton D, Bruce V.

J Geriatr Psychiatry Neurol. 2016 Jan;29(1):25-30. doi: 10.1177/0891988715598237. Epub 2015 Jul 30.

PMID:
26232406
17.

Is Seeing Believing? The Process of Change During Cognitive-behavioural Therapy for Distressing Visual Hallucinations.

Wilson R, Collerton D, Freeston M, Christodoulides T, Dudley R.

Clin Psychol Psychother. 2016 Jul;23(4):285-97. doi: 10.1002/cpp.1962. Epub 2015 Jun 3.

PMID:
26041275
18.

Patient and Informant Views on Visual Hallucinations in Parkinson Disease.

Urwyler P, Nef T, Müri RM, Killen A, Collerton D, Burn D, McKeith I, Mosimann UP.

Am J Geriatr Psychiatry. 2015 Sep;23(9):970-6. doi: 10.1016/j.jagp.2014.12.190. Epub 2014 Dec 30.

PMID:
25623941
19.

An exploratory study of the effectiveness of memory AIDS for older people living in supported accommodation.

Collerton D, Forster E, Packham D.

J Appl Gerontol. 2014 Dec;33(8):963-81. doi: 10.1177/0733464812456904. Epub 2012 Sep 17.

PMID:
25332304
20.

Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study.

Granic A, Hill TR, Kirkwood TB, Davies K, Collerton J, Martin-Ruiz C, von Zglinicki T, Saxby BK, Wesnes KA, Collerton D, Mathers JC, Jagger C.

Eur J Neurol. 2015 Jan;22(1):106-15, e6-7. doi: 10.1111/ene.12539. Epub 2014 Aug 13.

21.

Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life.

Lawson RA, Yarnall AJ, Duncan GW, Khoo TK, Breen DP, Barker RA, Collerton D, Taylor JP, Burn DJ.

Parkinsonism Relat Disord. 2014 Oct;20(10):1071-5. doi: 10.1016/j.parkreldis.2014.07.004. Epub 2014 Jul 18.

22.

Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease.

Waters F, Collerton D, Ffytche DH, Jardri R, Pins D, Dudley R, Blom JD, Mosimann UP, Eperjesi F, Ford S, Larøi F.

Schizophr Bull. 2014 Jul;40 Suppl 4:S233-45. doi: 10.1093/schbul/sbu036. Review.

23.

Quality of life and mild cognitive impairment in early Parkinson's disease: does subtype matter?

Lawson RA, Yarnall AJ, Duncan GW, Khoo TK, Breen DP, Barker RA, Collerton D, Taylor JP, Burn DJ.

J Parkinsons Dis. 2014;4(3):331-6. doi: 10.3233/JPD-140390.

PMID:
24919824
24.

Visual complaints and visual hallucinations in Parkinson's disease.

Urwyler P, Nef T, Killen A, Collerton D, Thomas A, Burn D, McKeith I, Mosimann UP.

Parkinsonism Relat Disord. 2014 Mar;20(3):318-22. doi: 10.1016/j.parkreldis.2013.12.009. Epub 2013 Dec 27.

PMID:
24405755
25.

Psychotherapy and brain plasticity.

Collerton D.

Front Psychol. 2013 Sep 6;4:548. doi: 10.3389/fpsyg.2013.00548. eCollection 2013. Review.

26.

Advances in the treatment of visual hallucinations in neurodegenerative diseases.

Collerton D, Taylor JP.

Future Neurol. 2013 Jul;8(4):433-444.

27.

Complex visual hallucinations and attentional performance in eye disease and dementia: a test of the Perception and Attention Deficit model.

Makin SM, Redman J, Mosimann UP, Dudley R, Clarke MP, Colbourn C, Collerton D.

Int J Geriatr Psychiatry. 2013 Dec;28(12):1232-8. doi: 10.1002/gps.3947. Epub 2013 Apr 5.

PMID:
23559442
28.

The assessment of cognition in visually impaired older adults.

Killen A, Firbank MJ, Collerton D, Clarke M, Jefferis JM, Taylor JP, McKeith IG, Mosimann UP.

Age Ageing. 2013 Jan;42(1):98-102. doi: 10.1093/ageing/afs157. Epub 2012 Oct 28.

29.

Identifying specific interpretations and use of safety behaviours in people with distressing visual hallucinations: an exploratory study.

Dudley R, Wood M, Spencer H, Brabban A, Mosimann UP, Collerton D.

Behav Cogn Psychother. 2012 May;40(3):367-75. doi: 10.1017/S1352465811000750. Epub 2012 Feb 10.

PMID:
22321567
30.

Dreaming and hallucinations - continuity or discontinuity? Perspectives from dementia with Lewy bodies.

Collerton D, Perry E.

Conscious Cogn. 2011 Dec;20(4):1016-20. doi: 10.1016/j.concog.2011.03.024. Epub 2011 Apr 30. Review.

PMID:
21531149
31.

Visual hallucinations.

Collerton D, Mosimann UP.

Wiley Interdiscip Rev Cogn Sci. 2010 Nov;1(6):781-786. doi: 10.1002/wcs.94.

PMID:
26271777
32.

Specific attentional impairments and complex visual hallucinations in eye disease.

Graham G, Dean J, Mosimann UP, Colbourn C, Dudley R, Clarke M, Collerton D.

Int J Geriatr Psychiatry. 2011 Mar;26(3):263-7. doi: 10.1002/gps.2522.

PMID:
20684031
33.

Cognitive style and depressive symptoms in elderly people - extending the empirical evidence for the cognitive vulnerability-stress hypothesis.

Meyer TD, Gudgeon E, Thomas AJ, Collerton D.

Behav Res Ther. 2010 Oct;48(10):1053-7. doi: 10.1016/j.brat.2010.06.003. Epub 2010 Jun 12.

PMID:
20591412
34.

A semi-structured interview to assess visual hallucinations in older people.

Mosimann UP, Collerton D, Dudley R, Meyer TD, Graham G, Dean JL, Bearn D, Killen A, Dickinson L, Clarke MP, McKeith IG.

Int J Geriatr Psychiatry. 2008 Jul;23(7):712-8. doi: 10.1002/gps.1965.

PMID:
18181237
35.

A comparison of computerized and pencil-and-paper tasks in assessing cognitive function in community-dwelling older people in the Newcastle 85+ Pilot Study.

Collerton J, Collerton D, Arai Y, Barrass K, Eccles M, Jagger C, McKeith I, Saxby BK, Kirkwood T; Newcastle 85+ Study Core Team.

J Am Geriatr Soc. 2007 Oct;55(10):1630-5. Epub 2007 Aug 14.

PMID:
17697099
36.

Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies.

Mosimann UP, Rowan EN, Partington CE, Collerton D, Littlewood E, O'Brien JT, Burn DJ, McKeith IG.

Am J Geriatr Psychiatry. 2006 Feb;14(2):153-60.

PMID:
16473980
37.

Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations.

Collerton D, Perry E, McKeith I.

Behav Brain Sci. 2005 Dec;28(6):737-57; discussion 757-94.

PMID:
16372931
38.

Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia.

Collerton D, Burn D, McKeith I, O'Brien J.

Dement Geriatr Cogn Disord. 2003;16(4):229-37. Review. Erratum in: Dement Geriatr Cogn Disord. 2005;19(1):56.

PMID:
14512718
39.

Dementia with Lewy bodies.

McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, McLaren A, Perry EK, Perry R, Piggott MA, O'Brien JT.

Semin Clin Neuropsychiatry. 2003 Jan;8(1):46-57. Review.

PMID:
12567332
40.

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH.

Neurology. 1996 Nov;47(5):1113-24. Review.

PMID:
8909416
41.

Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease.

Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, Fairbairn AF, Ince PG, Morris CM, Cheng AV, et al.

Alzheimer Dis Assoc Disord. 1993 Summer;7(2):69-79.

PMID:
8347330
42.

Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features.

Perry EK, Marshall E, Thompson P, McKeith IG, Collerton D, Fairbairn AF, Ferrier IN, Irving D, Perry RH.

J Neural Transm Park Dis Dement Sect. 1993;6(3):167-77.

PMID:
8123190
43.

Cholinergic function and intellectual decline in Alzheimer's disease.

Collerton D.

Neuroscience. 1986 Sep;19(1):1-28. Review. No abstract available.

PMID:
3537837
44.

Rational drug treatment of dementia.

Collerton D.

Br Med J (Clin Res Ed). 1985 Aug 3;291(6491):347-8. No abstract available.

45.

Cognitive performance of medicated schizophrenics with tardive dyskinesia.

Collerton D, Fairbairn A, Britton P.

Psychol Med. 1985 May;15(2):311-5.

PMID:
2862650
46.

Alzheimer's disease and the hippocampus.

Collerton D, Fairbairn A.

Lancet. 1985 Feb 2;1(8423):278-9. No abstract available.

PMID:
2857344

Supplemental Content

Loading ...
Support Center